Login
Navigate Fool.com
Will CYTK beat
the market?

Cytokinetics, Inc.

NASDAQ: CYTK

Community Rating: 3 Stars: Appealing

8.85 -0.60 (-6.35%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.47
Previous Close $9.45
Daily Range $8.35 - $9.59
52-Week Range $5.99 - $14.28
Market Cap $319.3M
P/E Ratio -7.62
Dividend (Yield) $0.00 (0.0%)
Volume 1,164,973
Average Daily Volume 940,065
Current FY EPS -$0.98

How do you think CYTK
will perform against the market?

Top CYTK Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 30, 2010

I could just as easily have entered a limit order to green thumb Cytokinetics at 2, since I'm not strongly sensing a bottom here, but I'm annoyed with my growing list of limit orders that aren't getti … More

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted June 7, 2009

Recent baby bio optimism and a bone from Amgen have combined to puff Cytokinetics stock to an eight month high. But CK-1827452 hasn't been shown to have any clinical benefit yet as trials so far have … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

3 Stocks That Absolutely Crushed the Market on Friday -- Here's Why athenahealth inc, Puma Biotechno

These health-care stocks have winning written all over them. Here's why athenahealth inc, Puma Biotechnology Inc, and Cytokinetics, Inc. popped on the market today.

Mid-Afternoon Market Update: Markets Post a Large Rally as Intuitive Surgical Shares Remain Down

Mid-Day Market Update: Alcoa Surges On Upbeat Earnings; Intuitive Surgical Shares Slip

Stocks: Insiders Buy at Titan International, Cytokinetics, and BioTime

Plus, a purchase at Clearfield.

Robust Gains for Healthcare Stocks; Cytokinetics Soars After Surprise Q4 Profit, 11-Fold Jump in Rev

Robust Gains for Healthcare Stocks; Cytokinetics Soars After Surprise Q4 Profit, 11-Fold Jump in Revenue

Sector Update: Healthcare

Why Cytokinetics Inc. Shares Soared

Cytokinetics shocked Wall Street with a surprise profit. Should investors be buying into this bullishness or would they be best served remaining cautious?

3 Things to Watch With Questcor

Can Questcor resume its tremendous year-to-date climb? Here are 3 factors that could make the difference.

Fallout From This Heart-Drug Failure

When a trial failure isn't all that bad.

Cheers and Jeers for Amgen's Pipeline

Amgen's heart drug may be revived, despite failure, all puns intended.

See More CYTK News...

Sector

Healthcare

Industry

Drugs

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks